3252
B.A. Al-Maythalony et al. / Inorganica Chimica Acta 363 (2010) 3244–3253
Fig. 12. 13C NMR for Se–Met–13C5 before (a) and after reaction with [Au(CN)4]ꢀ, in D2O at 25 °C and pD 12.0.
was oxidized into Met–SeO–CH3 [28–30] (Fig. 12). Signals were as-
signed by comparison with Se–Met oxidation experiment with
hydrogen peroxide [31–33]. Se–Met binding to gold metal center
is expected to be through selenium or amine group as reported
from computational work for methyl-seleno-cysteine by Shoeib
et al. [7].
Met was reported to be highly reactive with Au(III) ion [34], but
it showed no reactivity toward auricyanide even after stirring for
five days. So it can be concluded that cyanide ligand causes stabil-
ization for Au(III) against reaction with Met and Se–Met [35]. Lack
of reactivity of Met and Se–Met with [Au(CN)4]ꢀ complex could be
rationalized in terms of the strong Au(III)–CN bond at pH 7.4, how-
ever, basic solution at high pH (ꢂ12), which facilitates hydrolysis
that proceeds with ligand exchange reaction as shown by El-Kha-
teeb et al. [36]. They studied the interaction of Met with cis-platin
(cis-[(NH3)2PtCl2]) and reported that Met binding to cis-platin com-
plexes proceeds first by hydrolysis step of the complexes followed
by Met-S ligation. The carboxylate and amine groups enhanced the
reaction by electrostatic stabilization of the metal ligand complex
[37,38].
Acknowledgment
The authors would like to acknowledge the support by the
Deanship of Scientific Research at King Fahd University of
Petroleum and Minerals for funding this work through project
No. (IN080421). We also thank the Squibb Institute for Medical
Research, Princeton, NJ, USA for their generous gift of captopril.
References
[1] M.W. Whitehouse, Inflammopharmacology 16 (2008) 107.
[2] G.G. Graham, M.W. Whitehouse, G.R. Bushell, Inflammopharmacology 16
(2008) 126.
[3] A. Casini, M.A. Cinellu, G. Minghetti, C. Gabbiani, M. Coronnello, E. Mini, L.
Messori, J. Med. Chem. 49 (2006) 5524.
[4] L. Ronconi, L. Giovagnini, C. Marzano, F. Bettı‘o, R. Graziani, G. Pilloni, D.
Fregona, Inorg. Chem. 44 (2005) 1867.
[5] G.G. Graham, A.J. Kettle, Biochem. Pharmacol. 56 (1998) 307.
[6] J. Yeh, K. Huang, S. Lin, Y. Wu, C. Huang, S. Liou, J. Nanotechnol. (2000) 1.
[7] T. Shoeib, D.W. Atkinson, B.L. Sharp, Inorg. Chim. Acta 363 (2010) 184.
[8] P.M. Yangyuoru, J.W. Webb, C.F. Shaw, J. Inorg. Biochem. 102 (2008) 584.
[9] E.R.T. Tiekink, Inflammopharmacology 16 (2008) 138.
[10] A. Molter, F. Mohr, Coord. Chem. Rev. 254 (2010) 19.
[11] D.W. James, N.W. Ludvigsen, L.G. Cleland, J. Rheumatol. 9 (1982) 532.
[12] R.D. Hancock, N.P. Finnkelstein, A. Avers, J. Inorg. Nucl. Chem. 34 (1972) 3747.
[13] R.J. Puddephatt, The Chemistry of Gold, vol. 4, Elsevier, New York, 1978, p. 45.
[14] S. Ahmad, Coord. Chem. Rev. 248 (2004) 231.
4. Conclusion
[15] G.G. Graham, T.M. Haavisto, H.M. Jones, G.D. Champion, Biochem. Pharmacol.
33 (1984) 1257.
[16] P.M. Yangyuoru, J.W. Webb, C.F. Shaw III., J. Inorg. Biochem. 102 (2008) 576.
[17] R. Ettorre, M. Martelli, Inorg. Chim. Acta 108 (1985) 73.
[18] A.J. Canumalla, N. Al-Zamil, M. Phillips, A.A. Isab, C.F. Shaw III., J. Inorg.
Biochem. 85 (2001) 67.
[Au(CN)4]ꢀ shows high reactivity toward thiols. At low thiol ra-
tio, the reaction proceeds through exchange of one cyanide ligands
followed by reductive elimination of the disulfide from two mono-
substituted intermediates produce in formation of disulfide and
hexa-cyano-diaurate that disproportionates into auocyanide and
auricyanide. At higher thiol ratio, reaction proceeds through two
cyanide exchange followed by reductive elimination of the disul-
fide from cis-[(RS)2Au(CN)2]ꢀ intermediates along with Au(III)
reduction to Au(I) in the form of [Au(CN)2]ꢀ. Similar intermediates
were found for cap and GSH reactions with [Au(CN)4]ꢀ, indicating
similar reaction mechanism for these thiols, that depend on thiol
ratio in solution. Met and Se–Met were inert toward auricyanide
at pH 7.4 while some reactivity was observed for Se–Met at pH 12.
[19] A. Danoff, M.F. Sieveking, R.L. Lichter, S.N.Y. Fanso-Free, Org. Magn. Reson. 12
(2005) 83.
[20] Staszewska-Krajewska, J. Mol. Struct. 269 (2002) 602.
[21] G. Jonsall, P. Ahlberg, J. Am. Chem. Soc. 108 (1986) 3819.
[22] S.W. Griffiths, J. King, C.L. Cooney, J. Biol. Chem. 277 (2002) 25486.
[23] C.F. Shaw, M.P. Cancro, P.L. Witkiewicz, J.E. Eldridge, Inorg. Chem. 19 (1980)
3198.
[24] A.A. Isab, J. Inorg. Biochem. 30 (1987) 69.
[25] M.A. Hughes, G.L. Smith, D.R. Williams, Inorg. Chim. Acta 107 (1985) 247.
[26] G.L. Christie, M.A. Hughes, S.B. Rees, D.R. Williams, Inorg. Chim. Acta 15 (1988)
215.
[27] D.L. Rabenstein, A.A. Isab, Anal. Chem. 54 (1982) 526.